aCGT Vector are part of a public private partnership consortium that will invest €10.5m in bringing together a world class team of cellular therapy expertise. A world class GMP Licensed ATMP (Advanced Therapy Medicinal Products) Facility within a world renowned known world class GMP Licensed ATMP (Advanced Therapy Medicinal Products) Facility within a known Cellular Therapy and Cancer Centre of Excellence in St. James’s Hospital and Trinity College Dublin Clinical Research Facility. This ‘beyond translational‘ scientific collaboration will be the start of an initiative that will bring standardised and localised delivery of safe and effective transformational and potentially curative Cellular therapies to many more patients globally, by strategically locating aCGT Vector’s ATMP GMP-in-a-BOX in Cellular Therapy hospital centres of excellence. The overriding goal of aCGT Vector is make more Cellular Therapy Procedures more accessible to more Patients globally.